Fill-finish Pharmaceutical Contract Manufacturing Market by Product (Consumables, Instruments), End-users (Academic Research Institutions, Contract Manufacturing Organizations, Pharmaceutical & Biopharmaceutical Companies) - Global Forecast 2024-2030


Attention: There is an updated edition available for this report.

Fill-finish Pharmaceutical Contract Manufacturing Market by Product (Consumables, Instruments), End-users (Academic Research Institutions, Contract Manufacturing Organizations, Pharmaceutical & Biopharmaceutical Companies) - Global Forecast 2024-2030


The Fill-finish Pharmaceutical Contract Manufacturing Market size was estimated at USD 10.42 billion in 2023 and expected to reach USD 11.66 billion in 2024, at a CAGR 12.30% to reach USD 23.49 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Fill-finish Pharmaceutical Contract Manufacturing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Fill-finish Pharmaceutical Contract Manufacturing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Fill-finish Pharmaceutical Contract Manufacturing Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Baxter International, Inc., Boehringer Ingelheim International GmbH, Catalent Inc., Eurofins Scientific SE, Fresenius Kabi Contract Manufacturing, Gerresheimer AG, Groninger & Co. GmbH, MabPlex International Co. Ltd., Novartis AG, OPTIMA Packaging Group GmbH, Pfizer Inc., Recipharm AB, and Recro Pharma, Inc..

Market Segmentation & Coverage



This research report categorizes the Fill-finish Pharmaceutical Contract Manufacturing Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product
Consumables
Ampoules

Bottles

Cartridges

IV Bags

Prefilled Syringes

Vials
Instruments
Machine Type
Automated Machines

Semi-Automated & Manual Machines

Systems
Integrated Systems

Standalone Systems
End-users
Academic Research Institutions
Contract Manufacturing Organizations
Pharmaceutical & Biopharmaceutical Companies
Research & Development laboratories
Region
Americas
Argentina

Brazil

Canada

Mexico

United States
California

Florida

Illinois

New York

Ohio

Pennsylvania

Texas
Asia-Pacific
Australia

China

India

Indonesia

Japan

Malaysia

Philippines

Singapore

South Korea

Taiwan

Thailand

Vietnam
Europe, Middle East & Africa
Denmark

Egypt

Finland

France

Germany

Israel

Italy

Netherlands

Nigeria

Norway

Poland

Qatar

Russia

Saudi Arabia

South Africa

Spain

Sweden

Switzerland

Turkey

United Arab Emirates

United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Fill-finish Pharmaceutical Contract Manufacturing Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Fill-finish Pharmaceutical Contract Manufacturing Market?
3. What are the technology trends and regulatory frameworks in the Fill-finish Pharmaceutical Contract Manufacturing Market?
4. What is the market share of the leading vendors in the Fill-finish Pharmaceutical Contract Manufacturing Market?
5. Which modes and strategic moves are suitable for entering the Fill-finish Pharmaceutical Contract Manufacturing Market?

Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Fill-finish Pharmaceutical Contract Manufacturing Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Need to reduce overall investment for developing drugs
5.1.1.2. Increasing demand for fill-finish CMOs
5.1.1.3. Growing usage of multi-product-use-oriented facilities
5.1.2. Restraints
5.1.2.1. Concerns related to product failure, safety issues and loss of valuable product
5.1.3. Opportunities
5.1.3.1. Rising technological advancements in fill-finish manufacturing processes
5.1.3.2. Adoption of disposable or single-use equipment
5.1.4. Challenges
5.1.4.1. Stringent regulatory issues
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Fill-finish Pharmaceutical Contract Manufacturing Market, by Product
6.1. Introduction
6.2. Consumables
6.3.1. Ampoules
6.3.2. Bottles
6.3.3. Cartridges
6.3.4. IV Bags
6.3.5. Prefilled Syringes
6.3.6. Vials
6.3. Instruments
6.4.1. Machine Type
6.4.2.1. Automated Machines
6.4.2.2. Semi-Automated & Manual Machines
6.4.2. Systems
6.4.3.1. Integrated Systems
6.4.3.2. Standalone Systems
7. Fill-finish Pharmaceutical Contract Manufacturing Market, by End-users
7.1. Introduction
7.2. Academic Research Institutions
7.3. Contract Manufacturing Organizations
7.4. Pharmaceutical & Biopharmaceutical Companies
7.5. Research & Development laboratories
8. Americas Fill-finish Pharmaceutical Contract Manufacturing Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Fill-finish Pharmaceutical Contract Manufacturing Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam
10. Europe, Middle East & Africa Fill-finish Pharmaceutical Contract Manufacturing Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom
11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.2. Market Share Analysis, By Key Player
11.3. Competitive Scenario Analysis, By Key Player
12. Competitive Portfolio
12.1. Key Company Profiles
12.1.1. AbbVie Inc.
12.1.2. Baxter International, Inc.
12.1.3. Boehringer Ingelheim International GmbH
12.1.4. Catalent Inc.
12.1.5. Eurofins Scientific SE
12.1.6. Fresenius Kabi Contract Manufacturing
12.1.7. Gerresheimer AG
12.1.8. Groninger & Co. GmbH
12.1.9. MabPlex International Co. Ltd.
12.1.10. Novartis AG
12.1.11. OPTIMA Packaging Group GmbH
12.1.12. Pfizer Inc.
12.1.13. Recipharm AB
12.1.14. Recro Pharma, Inc.
12.2. Key Product Portfolio
13. Appendix
13.1. Discussion Guide
13.2. License & Pricing
FIGURE 1. FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET RESEARCH PROCESS
FIGURE 2. FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2023 VS 2030
FIGURE 3. FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET DYNAMICS
FIGURE 7. FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2023 VS 2030 (%)
FIGURE 10. FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 12. AMERICAS FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 14. UNITED STATES FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. ASIA-PACIFIC FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. ASIA-PACIFIC FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 20. FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SHARE, BY KEY PLAYER, 2023

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings